ELIZABETH PRIETO: Open Payments
NPI 1730796103 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 80 payments from 16 companies in 2025. Trend: 2023 $602 · 2024 $1,440 · 2025 $1,556
Food & beverage: $1,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $188 |
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| Novo Nordisk Inc | 10 | $174 |
| PFIZER INC. | 7 | $130 |
| Bausch Health US, LLC | 7 | $128 |
| Lilly USA, LLC | 7 | $118 |
| Abbott Laboratories | 3 | $91 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Dexcom, Inc. | 3 | $65 |
Products named: JARDIANCE, APLENZIN, FREESTYLE LIBRE 3, UBRELVY, VRAYLAR, TRELEGY ELLIPTA, QULIPTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
